178 related articles for article (PubMed ID: 23121893)
1. Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge.
Roy S; Smith MA; Cieply KM; Acquafondata MB; Parwani AV
Diagn Pathol; 2012 Nov; 7():151. PubMed ID: 23121893
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.
Raspollini MR; Nesi G; Baroni G; Girardi LR; Taddei GL
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):358-62. PubMed ID: 16280666
[TBL] [Abstract][Full Text] [Related]
3. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Osunkoya AO; Epstein JI
Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N
Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
Wang HL; Lu DW; Yerian LM; Alsikafi N; Steinberg G; Hart J; Yang XJ
Am J Surg Pathol; 2001 Nov; 25(11):1380-7. PubMed ID: 11684954
[TBL] [Abstract][Full Text] [Related]
6. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
[TBL] [Abstract][Full Text] [Related]
7. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
Bayrak R; Haltas H; Yenidunya S
Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
[TBL] [Abstract][Full Text] [Related]
8. Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
Suh N; Yang XJ; Tretiakova MS; Humphrey PA; Wang HL
Mod Pathol; 2005 Sep; 18(9):1217-22. PubMed ID: 15803184
[TBL] [Abstract][Full Text] [Related]
9. Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
Giannico GA; Gown AM; Epstein JI; Revetta F; Bishop JA
Hum Pathol; 2017 Sep; 67():152-159. PubMed ID: 28711650
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma of the urinary bladder.
Roy S; Parwani AV
Arch Pathol Lab Med; 2011 Dec; 135(12):1601-5. PubMed ID: 22129192
[TBL] [Abstract][Full Text] [Related]
11. p-120 Catenin is a Useful Diagnostic Biomarker for Distinguishing Plasmacytoid and Sarcomatoid Variants From Conventional Urothelial Carcinoma.
Acosta AM; Barletta J; Sonpavde G; Schnitt S; Hirsch MS
Arch Pathol Lab Med; 2021 Aug; 145(8):1000-1008. PubMed ID: 33237989
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.
Rao Q; Williamson SR; Lopez-Beltran A; Montironi R; Huang W; Eble JN; Grignon DJ; Koch MO; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Cheng L
Mod Pathol; 2013 May; 26(5):725-32. PubMed ID: 23348900
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder.
Broede A; Oll M; Maurer A; Siegert S; Stoerkel S; Golz R; Schwamborn K; Veeck J; Knuechel R; Gaisa NT;
J Clin Pathol; 2016 Apr; 69(4):307-12. PubMed ID: 26463756
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
[TBL] [Abstract][Full Text] [Related]
15. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.
Paner GP; McKenney JK; Barkan GA; Yao JL; Frankel WL; Sebo TJ; Shen SS; Jimenez RE
Am J Surg Pathol; 2011 Jun; 35(6):787-98. PubMed ID: 21572312
[TBL] [Abstract][Full Text] [Related]
17. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel.
Tamboli P; Mohsin SK; Hailemariam S; Amin MB
Arch Pathol Lab Med; 2002 Sep; 126(9):1057-63. PubMed ID: 12204054
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.
Matsushima J; Yazawa T; Suzuki M; Takahashi Y; Ota S; Nakajima T; Yoshino I; Yokose T; Inoue T; Kawahara K; Nakatani Y
Hum Pathol; 2017 Jun; 64():179-185. PubMed ID: 28438615
[TBL] [Abstract][Full Text] [Related]
19. The Diagnostic Value of Cadherin 17 and CDX2 Expression as Immunohistochemical Markers in Colorectal Adenocarcinoma.
Abouelkhair MB; Mabrouk SH; Zaki SSA; Nada OH; Hakim SA
J Gastrointest Cancer; 2021 Sep; 52(3):960-969. PubMed ID: 32929682
[TBL] [Abstract][Full Text] [Related]
20. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma.
Logani S; Oliva E; Arnell PM; Amin MB; Young RH
Mod Pathol; 2005 Jan; 18(1):19-25. PubMed ID: 15389251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]